Clinical Trial

Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This phase 3 clinical trial will compare use of individual treatment with mirabegron or desmopressin and their combination for treatment of non-monosymptomatic nocturnal enuresis in children
Trial Details
NCT Number NCT07398261
Lead Sponsor Menoufia University
Conditions Treatment of Non-monosymptomatic Nocturnal Enuresis
Enrollment 151 participants
Start Date 2023-08-28
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-09